Psychiatry and Neurology, Neurology · New York, NY
NPI
1245206788
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
423 E 23rd St, VA New York Harbor Healthcare System - Manhattan Campus
New York, NY, 10010
Phone (212) 686-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,936
63 services
Medicare patients, 2024
32
Average age 64
Drug cost, 2024
$644K
689 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Beth A Leeman-Markowski was code 99214 (office e&m - established), 42 times for 26 patients. In total Beth A Leeman-Markowski billed 63 services in 6 codes, and Medicare paid $6,936.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 42 | 26 | $103.53 | $4,348 |
| 99215 Office E&M - Established | Office | 15 | 15 | $142.91 | $2,144 |
By year: 2022 $9,922 for 86 services; 2023 $7,906 for 68 services; 2024 $6,936 for 63 services.
Medicare prescription drug claims, 2024
In 2024, the drug Beth A Leeman-Markowski prescribed most often to Medicare patients was Lamotrigine Er (Lamotrigine), with 73 prescriptions and refills. In total Beth A Leeman-Markowski wrote 689 Medicare prescriptions that cost $644K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Er Lamotrigine | 73 | 105 | Under 11 | $14K |
| Levetiracetam Generic | 63 | 114 | 11 | $3,478 |
| Lamotrigine Generic | 53 | 105 | Under 11 | $1,373 |
| Lacosamide Generic | 53 | 76 | Under 11 | $10K |
| Topiramate Generic | 52 | 68 | Under 11 | $1,329 |
| Felbamate Generic | 42 | 52 | Under 11 | $18K |
| Levetiracetam Er Levetiracetam | 35 | 67 | Under 11 | $2,269 |
| Zonisamide Generic | 32 | 46 | Under 11 | $1,058 |
| Divalproex Sodium Er Divalproex Sodium | 26 | 26 | Under 11 | $643 |
| Fycompa Perampanel | 17 | 23 | Under 11 | $27K |
| Divalproex Sodium Generic | 17 | 17 | Under 11 | $103 |
| Vimpat Lacosamide | 14 | 22 | Under 11 | $17K |
| Clobazam Generic | 14 | 38 | Under 11 | $5,513 |
| Sabril Vigabatrin | 13 | 13 | Under 11 | $481K |
| Oxcarbazepine Generic | 13 | 39 | Under 11 | $942 |
Brand drugs: - claims; generic drugs: 600 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Beth A Leeman-Markowski were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.